Substance Use Disorders and Pain Management: MATE Act Training

Substance use disorders continue to be an important health issue in the United States and can lead to significant problems in all aspects of a person's life. Appropriate assessment and management of substance use is a priority in patient care. In addition, the presence of substance use disorders can complicate the treatment or management of comorbid medical conditions. Given the ongoing prescription opioid (and illicitly manufactured fentanyl) use and overdose epidemic in the United States and the widespread incidence of chronic pain, opioid prescribing and optimum safe pain management is a public health concern. All clinicians should have good knowledge of the available options for substance use disorder treatment and for safe opioid prescribing and dispensing.

The purpose of this course is to provide clinicians who prescribe or distribute controlled substances with an appreciation for the complexities of managing patients with substance use disorders and comorbid pain in order to provide the best possible patient care and to prevent a growing social problem.

This course is designed to meet the Federal MATE Act requirement for new or renewing DEA licensees for 8 hours of training on opioid or other substance use disorders and the appropriate treatment of pain.

Learning Objectives

Upon completion of this course, you should be able to:

  1. Outline substance use disorder risk factors, screening, and diagnosis.
  2. Describe the role of psychosocial therapies in the management of substance use disorders.
  3. Compare and contrast available pharmacotherapeutic options for the treatment of alcohol, tobacco, and opioid use disorders.
  4. Discuss the impact of polysubstance use and co-occurring mental disorders and substance use disorder presentation and treatment.
  5. Review legal and ethical issues related to substance use disorder treatment.
  6. Create comprehensive treatment plans for patients with pain that address patient needs as well as drug diversion prevention.
  7. Evaluate behaviors that may indicate drug seeking or diverting as well as approaches for patients suspected of misusing opioids.
  8. Identify state and federal laws governing the proper prescription and monitoring of controlled substances.

95300

Additional Information

Partner: 
NetCE
Course summary
Available credit: 
  • 8.00 AANP Pharmacology Contact Hours
  • 8.00 AMA PRA Category 1 Credit™
  • 8.00 ANCC
Course opens: 
05/01/2023
Course expires: 
04/30/2026
Cost:
$69.00
Rating: 
0

Available Credit

  • 8.00 AANP Pharmacology Contact Hours
  • 8.00 AMA PRA Category 1 Credit™
  • 8.00 ANCC

Price

Cost:
$69.00
Please login or register to take this course.

This course is offered through NetCE.

To take this course you will be redirected to NetCE website. You must login or create an account with NetCE in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch